ARCHIVES

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 10, 1989

Download PDF Visit The Full Archive

Related Articles

Cancer Education Applications Suspended Pending Restructuring

March 21, 1986

Copyright Violation Of Cancer Letter – Results In Payment

July 19, 1991

Fragmin Cuts Risk Of VE By 50 Percent In Study

January 31, 2003

NCAB Committee, NCI Split On Starting New Organ Systems Autodigestive Group

February 15, 1985

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011

House Appropriator Claims NCI, NLM Grants Funded Political Activity, Seeks OIG Probe

March 22, 2013